preventing < prevention < preventive

Facettes :

List of bibliographic references indexed by prevention

Number of relevant bibliographic references: 11.

Ident.	Authors (with country if any)	Title
000547 (2010)	Hanne Madsen [Danemark] ; Kim Brixen [Danemark] ; Jesper Hallas [Danemark]	Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease – a population‐based database study
001028 (2007)	Bhomraj Thanvi [Royaume-Uni] ; Nelson Lo ; Tom Robinson	Levodopa-induced dyskinesia in Parkinson’s disease: clinical features, pathogenesis, prevention and treatment
001223 (2006)	Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]	Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin
001663 (2004)	Alberto Ascherio ; Marc G. Weisskopf ; Eilis J. O Eilly ; Marjorie L. Mccullough ; Eugenia E. Calle ; Carmen Rodriguez ; Michael J. Thun	Coffee Consumption, Gender, and Parkinson’s Disease Mortality in the Cancer Prevention Study II Cohort: The Modifying Effects of Estrogen
001B69 (2000)	Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada]	Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice
001C33 (2000)	Rosalyn Singleton [États-Unis] ; Lisa R. Bulkow [États-Unis] ; Orin S. Levine [États-Unis] ; Jay C. Butler [États-Unis] ; Thomas W. Hennessy [États-Unis] ; Alan Parkinson [États-Unis]	Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: The impact of persistent oropharyngeal carriage
001D52 (1999)	Marcel E. Salive ; David H. Stein	Predictors and Correlates of Prevention Research Careers: A National Study of Residency Graduates
002025 (1997)	M. Maral Mouradian ; Thomas N. Chase	Gene Therapy for Parkinson's Disease: An Approach to the Prevention or Palliation of Levodopa-Associated Motor Complications
002284 (1995)	J. Knoll [Hongrie]	Rationale for (−)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes
002352 (1995)	G. Mathé [France]	Can an adjuvant treatment or a pharmacologic prevention be common to several diseases? The case of those associated to neuromediator defects
002612 (1992)		Sixth annual symposium on etiology, pathogenesis, and prevention of Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "prevention" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "prevention" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    prevention
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024